300199SZSE
🚨 Material Event

Resolution Announcement of the 16th Meeting of the 6th Board of Directors

Hybio Pharmaceutical Co., Ltd.··2 pages

✨ AI Summary

Shenzhen Hanyu Pharmaceutical Co., Ltd. held its 16th Board of Directors meeting. The board approved the first grant of restricted shares to 111 eligible employees, totaling 17.35 million shares at a price of 11.61 RMB per share. The meeting's resolutions were legally convened and valid.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 300199 Stock Abbreviation: Hanyu Pharmaceutical Announcement No.: 2026-048

Shenzhen Hanyu Pharmaceutical Co., Ltd.

Resolution Announcement of the 16th Meeting of the 6th Board of Directors

The Company and all members of the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.

I. Convening of the Board Meeting

Shenzhen Hanyu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") issued a notice via email and telephone to all directors of the Company on July 15, 2026, regarding the convening of the 16th meeting of the 6th Board of Directors.

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.